Skip to main content

Advertisement

Table 2 Results on total and allergic/non-allergic drug costs by year after SCITonset (analytic) – not involving SCIT intervention costs

From: Influence of subcutaneous specific immunotherapy on drug costs in children sufferingfrom allergic asthma

Years after SCIT onset SCIT Control p-value
Total drug costs in euro [mean (95% CI)]
1. year 319 (236 to 402) 364 (262 to 466) 0.716
2. year 250 (168 to 333) 389 (272 to 506) 0.077
3. year 193 (114 to 273) 498 (293 to 702) 0.001
Allergic drug costs in euro [mean (95% CI)]
1. year 270 (197 to 343) 306 (219 to 393) 0.716
2. year 206 (135 to 277) 341 (232 to 451) 0.021
3. year 168 (94 to 242) 453 (249 to 656) 0.002
Non-Allergic drug costs in euro [mean (95% CI)]
1. year 49 (24 to 75) 58 (16 to 100) 0.233
2. year 44 (13 to 75) 47 (7 to 88) 0.262
3. year 25 (2 to 48) 45 (0 to 92) 0.373